Quent Capital LLC Sells 906 Shares of CVS Health Co. (NYSE:CVS)

Quent Capital LLC lowered its stake in shares of CVS Health Co. (NYSE:CVS) by 30.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,029 shares of the pharmacy operator’s stock after selling 906 shares during the quarter. Quent Capital LLC’s holdings in CVS Health were worth $91,000 at the end of the most recent quarter.

Several other institutional investors have also bought and sold shares of CVS. MidAtlantic Capital Management Inc. bought a new stake in CVS Health during the third quarter worth $25,000. Ridgewood Investments LLC grew its holdings in CVS Health by 255.7% during the fourth quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock worth $28,000 after buying an additional 450 shares in the last quarter. Stonebridge Financial Group LLC purchased a new position in CVS Health in the fourth quarter worth $28,000. Livelsberger Financial Advisory purchased a new position in CVS Health in the third quarter worth $31,000. Finally, Legacy Investment Solutions LLC purchased a new position in CVS Health in the third quarter worth $31,000. Institutional investors own 80.66% of the company’s stock.

Analyst Upgrades and Downgrades

CVS has been the topic of several research analyst reports. TD Cowen boosted their price objective on CVS Health from $73.00 to $80.00 and gave the stock a “buy” rating in a research report on Monday, November 25th. UBS Group cut their price objective on CVS Health from $62.00 to $59.00 and set a “neutral” rating on the stock in a research report on Tuesday. Wells Fargo & Company raised CVS Health from an “equal weight” rating to an “overweight” rating and boosted their price objective for the stock from $60.00 to $66.00 in a research report on Monday, November 18th. Cantor Fitzgerald raised CVS Health from a “neutral” rating to an “overweight” rating in a research report on Wednesday. Finally, Barclays dropped their price target on CVS Health from $75.00 to $71.00 and set an “overweight” rating on the stock in a research report on Thursday, November 7th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have issued a buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $67.78.

CVS Health Stock Performance

Shares of CVS opened at $63.23 on Thursday. The stock’s 50-day simple moving average is $50.61 and its 200 day simple moving average is $55.92. The stock has a market capitalization of $79.57 billion, a price-to-earnings ratio of 16.05, a price-to-earnings-growth ratio of 0.60 and a beta of 0.61. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.59 and a current ratio of 0.80. CVS Health Co. has a 52-week low of $43.56 and a 52-week high of $80.75.

CVS Health (NYSE:CVS) last announced its earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share for the quarter, topping analysts’ consensus estimates of $0.89 by $0.30. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. Research analysts forecast that CVS Health Co. will post 5.14 EPS for the current fiscal year.

CVS Health Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd were paid a $0.665 dividend. The ex-dividend date of this dividend was Thursday, January 23rd. This represents a $2.66 dividend on an annualized basis and a yield of 4.21%. CVS Health’s dividend payout ratio is currently 67.51%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.